Clinical Study

A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squamous Cell Carcinoma.

Posted Date: Feb 7, 2018

  • Investigator: Trisha Wise-Draper
  • Specialties: Head & Neck Cancer, Cancer
  • Type of Study: Drug

The purpose of this research study is to test the safety of adding metformin to treatment that you will already be getting for your cancer. You will be offered “standard of care” treatment whether you participate in this study or not. The standard of care treatment will be cisplatin once every 3 weeks for 3 treatments and radiation for 7 weeks. The risks and benefits of the standard of care treatment will be discussed by your regular doctor.


To Be Eligible To Participate, Patients Must Have Head And Neck Cancer That Requires Treatment With Cisplatin And Radiation.


Head & Neck, Ucci-Hn-14-01, Squamous Cell, Cancer

For More Information:

Uc Cancer Institute

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.